Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Laropiprant> ?p ?o. }
Showing items 1 to 74 of
74
with 100 items per page.
- Laropiprant abstract "Laropiprant (INN) is used in combination with niacin to reduce blood cholesterol (LDL and VLDL). Merck & Co. planned to market this combination under the trade names Cordaptive in the US and Tredaptive in Europe. Both brands contain 1000 mg of niacin and 20 mg of laropiprant in each tablet. Laropiprant itself has no cholesterol lowering effect, but it reduces facial flushes induced by niacin. In a trial with 1613 patients, 10.2% patients stopped taking the medication in the combination drug group versus 22.2% under niacin monotherapy.".
- Laropiprant atcPrefix "C10".
- Laropiprant atcPrefix "none".
- Laropiprant atcSuffix "AD52".
- Laropiprant casNumber "571170-77-9".
- Laropiprant fdaUniiCode "G7N11T8O78".
- Laropiprant iupacName "(-)-[(3R)-4-(4-chlorobenzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]acetic acid".
- Laropiprant pubchem "11948701".
- Laropiprant pubchem "9867642".
- Laropiprant thumbnail Laropiprant.png?width=300.
- Laropiprant wikiPageID "17508796".
- Laropiprant wikiPageRevisionID "592155325".
- Laropiprant atcPrefix "10.0".
- Laropiprant atcPrefix "none".
- Laropiprant atcSuffix "AD52".
- Laropiprant c "21".
- Laropiprant casNumber "571170".
- Laropiprant chembl "426559".
- Laropiprant chemspiderid "8043333".
- Laropiprant cl "1".
- Laropiprant class Hypolipidemic_agent.
- Laropiprant class Prostaglandin_receptor.
- Laropiprant class Receptor_antagonist.
- Laropiprant component "Laropiprant".
- Laropiprant component "Niacin".
- Laropiprant drugName "Laropiprant".
- Laropiprant drugName "Niacin/laropiprant".
- Laropiprant f "1".
- Laropiprant h "19".
- Laropiprant hasPhotoCollection Laropiprant.
- Laropiprant iupacName "-[-4--7-fluoro-5--1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]acetic acid".
- Laropiprant kegg "D08940".
- Laropiprant legalStatus "Withdrawn".
- Laropiprant licenceEu "Tredaptive".
- Laropiprant molecularWeight "435.9".
- Laropiprant n "1".
- Laropiprant o "4".
- Laropiprant pubchem "11948701".
- Laropiprant pubchem "9867642".
- Laropiprant routesOfAdministration "Oral".
- Laropiprant s "1".
- Laropiprant smiles "O=SC".
- Laropiprant stdinchi "1".
- Laropiprant stdinchikey "NXFFJDQHYLNEJK-CYBMUJFWSA-N".
- Laropiprant synonyms "MK-0524A".
- Laropiprant tradename "Cordaptive, Tredaptive".
- Laropiprant type "combo".
- Laropiprant unii "G7N11T8O78".
- Laropiprant verifiedfields "changed".
- Laropiprant verifiedrevid "408651073".
- Laropiprant watchedfields "changed".
- Laropiprant subject Category:Combination_drugs.
- Laropiprant subject Category:Indoles.
- Laropiprant subject Category:Merck.
- Laropiprant subject Category:Organochlorides.
- Laropiprant subject Category:Organofluorides.
- Laropiprant subject Category:Sulfones.
- Laropiprant type Drug.
- Laropiprant type DrugProduct.
- Laropiprant type FunctionalSubstance.
- Laropiprant comment "Laropiprant (INN) is used in combination with niacin to reduce blood cholesterol (LDL and VLDL). Merck & Co. planned to market this combination under the trade names Cordaptive in the US and Tredaptive in Europe. Both brands contain 1000 mg of niacin and 20 mg of laropiprant in each tablet. Laropiprant itself has no cholesterol lowering effect, but it reduces facial flushes induced by niacin.".
- Laropiprant label "Associação ácido nicotínico/laropiprant".
- Laropiprant label "Laropiprant".
- Laropiprant label "Laropiprant".
- Laropiprant sameAs Laropiprant.
- Laropiprant sameAs laropiprant.
- Laropiprant sameAs m.04g1pwn.
- Laropiprant sameAs Q412291.
- Laropiprant sameAs Q412291.
- Laropiprant wasDerivedFrom Laropiprant?oldid=592155325.
- Laropiprant depiction Laropiprant.png.
- Laropiprant isPrimaryTopicOf Laropiprant.
- Laropiprant name "Laropiprant".
- Laropiprant name "Niacin/laropiprant".
